Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline diabetes drug faces U.S. approval delay
GlaxoSmithKline diabetes drug faces U.S. approval delay
GlaxoSmithKline diabetes drug faces U.S. approval delay
Submitted by
admin
on August 3, 2013 - 10:11am
Source:
Reuters
News Tags:
albiglutide
type 2 diabetes
diabetes
Headline:
GlaxoSmithKline diabetes drug faces U.S. approval delay
Do Not Allow Advertisers to Use My Personal information
